Po‐Lan Su

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

Po‐Lan Su, Yi‐Lin Wu, Wei-Hung Chang et al. · Therapeutic Advances in Medical Oncology · 2018 · 51 citations · Full text

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

Wei-Hung Chang, Yi‐Lin Wu, Po‐Lan Su et al. · PLoS ONE · 2018 · 47 citations · Full text

Distant Metastasis, Iii Nsclc Patients, Pathology +17

Comparison of different staging methods for COPD in predicting outcomes

Tang‐Hsiu Huang, Tzuen‐Ren Hsiue, Sheng‐Hsiang Lin et al. · European Respiratory Journal · 2018 · 36 citations · Full text

An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

Shang-Gin Wu, Chi‐Lu Chiang, Chien-Ying Liu et al. · Frontiers in Oncology · 2020 · 34 citations · Full text

Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - A retrospective cohort study

Chin‐Wei Kuo, Sheng‐Yuan Wang, Huey-Pin Tsai et al. · Journal of Microbiology Immunology and Infection · 2021 · 24 citations · Full text